Can SAGA Metals Corp. turn a Rio Tinto castoff into Quebec’s next titanium discovery story? (TSXV: SAGA)
What Olaplex Holdings, Inc.’s $2.06-per-share buyout by Henkel AG & Co. KGaA signals for beauty sector consolidation (NASDAQ: OLPX)
What Cadre Holdings, Inc.’s $10.3m acquisition signals about consolidation in tactical gear markets (NYSE: CDRE)
Rhinebeck Bank taps MANTL for omnichannel account opening as Alkami Technology (ALKT) accelerates post-acquisition integration
Read More 2 minute read Pharma Industry News Takeda’s NINLARO fails to meet PFS primary endpoint in TOURMALINE-MM2 trial Takeda Pharmaceutical said that the Phase 3 TOURMALINE-MM2 trial in newly diagnosed multiple myeloma patients for NINLARO (ixazomib)… bypharmanewsdailySeptember 11, 2020
